targets,factors
v_AKT, (((v_mTOR | v_PDK1) | v_AKT) | v_ERBB3)
v_EGF, v_EGF
v_ERBB1, (((v_ERBB1 & !(v_pertuzumab | v_erlotinib)) | (v_EGF & !(v_pertuzumab | v_erlotinib))) | (v_PLCg & !(v_pertuzumab | v_erlotinib)))
v_ERBB2, (v_ERBB2 & !((v_trastuzumab | v_pertuzumab) | v_erlotinib))
v_ERBB3, ((v_ERBB3 & !(v_erlotinib | v_pertuzumab)) | (v_HRG & !(v_erlotinib | v_pertuzumab)))
v_ERK1_2, (((v_PDK1 | v_ERBB3) | v_MEK1_2) | v_ERK1_2)
v_HRG, v_HRG
v_MEK1_2, (((v_ERBB2 | v_ERBB3) | v_ERBB1) | v_MEK1_2)
v_PDK1, (((v_ERBB2 | v_ERBB1) | v_PDK1) | v_ERBB3)
v_PKCa, (v_PLCg | v_PKCa)
v_PLCg, (((v_ERBB2 | v_ERBB3) | v_ERBB1) | v_PLCg)
v_erlotinib, v_erlotinib
v_mTOR, (v_mTOR | v_AKT)
v_p70S6K, (((v_p70S6K | v_AKT) | v_mTOR) | v_ERK1_2)
v_pertuzumab, v_pertuzumab
v_trastuzumab, v_trastuzumab
